It exerts its oncogenic role by preventing cells from undergoing apoptosis. BCL-2 overexpression not only leads to the resistance of cancer cells towards chemotherapy, radiation, and hormone therapy but also causes an aggressive tumor phenotype in patients with a variety of cancers [12]. Here, BCL2 is linked to neoplasm.